Chief Financial Officer · PRECISION BIOSCIENCES INC · Common Stock
Side
SELL
Value
$61K
Shares
15.2K
Price
$4.03
Executed
Jan 21, 2026
Disclosed
Jan 22, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 21 executedJan 22, 2026 disclosed
DTIL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Kelly John Alexander filed this Form 4 reporting a open-market sale of DTIL on Jan 21, 2026. It became public on Jan 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Kelly John Alexandercik:0001590030
Issuer
PRECISION BIOSCIENCES INCcik:0001357874
Revision history · 0
No field has changed since this record was first ingested.
